Rhythm control should be better for the management of patients with atrial fibrillation and heart failure: Rhythm control vs. rate control: Which is better in the management of atrial fibrillation? (Rhythm-side)

Circulation Journal

Volumn 75, Issue 4, 2011, Pages 979-985

  Kurita, Takashi ^a   Motoki, Koichiro ^a   Yasuoka, Ryobun ^a   Hirota, Takayoshi ^a   Akaiwa, Yuzuru ^a   Kotake, Yasuhito ^a   Miyazaki, Shunichi ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Antiarrhythmic drug; Atrial fibrillation; Catheter ablation; Heart failure

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ARTICLE; ATRIOVENTRICULAR CONDUCTION; CARDIOVERSION; CATHETER ABLATION; DISEASE CONTROL; DRUG EFFICACY; HEART ATRIUM CONTRACTION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART VENTRICLE PACING; HEART VENTRICLE PERFORMANCE; HUMAN; PULMONARY VEIN ISOLATION; RR INTERVAL; SINUS RHYTHM; SURVIVAL RATE; UNSPECIFIED SIDE EFFECT;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HEART FAILURE; HEART RATE; HUMANS; MALE;

EID: 79953650094     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0075     Document Type: Article

References (29)

1. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: Epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003; 91(Suppl): 2D-8D.
2. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98: 946-952.
3. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LV. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials: Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998; 32: 695-703.
4. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure: A study of 390 patients. Circulation 1991; 84: 40-48.
5. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-1435.
6. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833.
7. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation-Pharmacologic Intervention in Atrial Fibrillation (PIAF): A randomized trial. Lancet 2000; 356: 1789-1794.
8. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-1840.
9. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, et al. STAF Investigators. Randomized trial of rate-control versus rhythmcontrol in persistent atrial fibrillation: The Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003; 41: 1690-1696.
10. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, et al; Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008; 358: 2667-2677.
11. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, et al; AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004; 109: 1509-1513.
12. Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT). Circulation 1998; 98: 2574-2579.
13. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666.
14. Haïssaguerre M, Jaïs P, Shah DC, Garrigue S, Takahashi A, Lavergne T, et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000; 101: 1409-1417.
15. Pappone C, Oreto G, Rosanio S, Vicedomini G, Tocchi M, Gugliotta F, et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: Efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 2001; 104: 2539-2544.
16. Oral H, Ozaydin M, Tada H, Chugh A, Hassan S, Scharf C, et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002; 105: 1077-1081.
17. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A metaanalysis of randomized controlled trials. Circulation 1990; 82: 1106-1116.
18. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992; 20: 527-532.
19. Hsu LF, Jaïs P, Sanders P, Garrigue S, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004; 351: 2373-2383.
20. Brignole M, Menozzi C, Gasparini M, Bongiorni MG, Botto GL, Ometto R, et al. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J 2002; 23: 892-900.
21. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, et al; Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288: 3115-3123.
22. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
23. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549.
24. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 2006; 27: 1928-1932.
25. Khan MN, Jaïs P, Cummings J, Di Biase L, Sanders P, Martin DO, et al; PABA-CHF Investigators. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 2008; 359: 1778-1785.
26. Nagai T, Satomi K, Noda T, Okamura H, Yamada Y, Shimizu W, et al. Relationship between oral amiodarone and inappropriate therapy from an implantable cardioverter defibrillator. Circ J 2010; 74: 1302-1307.
27. Ogawa S, Yamashita T, Yamazaki T, Aizawa Y, Atarashi H, Inoue H, et al; J-RHYTHM Investigators. Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study. Circ J 2009: 73: 242-248.
28. Aizawa Y, Kohsaka S, Suzuki S, Atarashi H, Kamakura S, Sakurai M, et al; J-RHYTHM Investigators. Comparison of antiarrhythmics used in patients with paroxysmal atrial fibrillation: Subanalysis of J-RHYTHM Study. Circ J 2010; 74: 71-76.
29. Chinushi M, Iijima K. Rate control is a better initial treatment for patients with atrial fibrillation and heart failure: Rhythm control vs. rate control: Which is better in the management of atrial fibrillation? (Rate-Side) Circ J 2011; 75: 970-978.